Investors File Class Action Against PROCEPT BioRobotics Over Revenue Claims

The complaint filed against the NASDAQ-listed company claims violations of the Securities Exchange Act of 1934. According to the allegations, PROCEPT BioRobotics pulled sales forward from future periods through heavy discounting, which resulted in a significant inventory glut. These actions allegedly rendered the company's public financial statements materially misleading to shareholders throughout the two-year class period.

The DJS Law Group, led by David J. Schwartz, is representing the class and seeking individuals who suffered losses during this window. While investors may apply for lead plaintiff status, participation in potential financial recovery does not require this formal appointment. The firm, which maintains a practice focused on securities litigation and corporate governance, is currently coordinating with affected shareholders to consolidate claims before the court-mandated cutoff.